RhumbLine Advisers’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Buy |
|
|||||
|
2025
Q1 | $218K | Sell |
|
|||||
|
2024
Q4 | $341K | Buy |
|
|||||
|
2024
Q3 | $691K | Sell |
|
|||||
|
2024
Q2 | $641K | Buy |
|
|||||
|
2024
Q1 | $468K | Buy |
|
|||||
|
2023
Q4 | $564K | Buy |
|
|||||
|
2023
Q3 | $467K | Buy |
|
|||||
|
2023
Q2 | $298K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $122K | Buy |
|
|||||
|
2021
Q4 | $247K | Sell |
|
|||||
|
2021
Q3 | $731K | Buy |
|
|||||
|
2021
Q2 | $367K | Buy |
|
|||||
|
2021
Q1 | $364K | Buy |
|